DCGI Chief Dr V G Somani tenure extended by 3 months Ruchika Sharma17 Aug 2022 5:00 PM ISTNew Delhi: The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued...
Serum Institute to supply 1 crore qHPV vaccine doses by December: Sources Ruchika Sharma2 Aug 2022 11:34 AM ISTCervical cancer in India ranks as the second most frequent cancer among women aged between 15 and 44 years.
NTAGI panel reviews data for Biological E Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma22 July 2022 3:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Corbevax, is currently being used to inoculate children in the age group of 12 to 14...
SII to launch QHPV vaccine against cervical cancer Rahul Verma14 July 2022 10:42 AM ISTIndia's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India's (DCGI) approval for...
FIRST: Serum Institute gets DCGI nod for qHPV vaccine against cervical cancer Ruchika Sharma13 July 2022 11:37 AM ISTThe National Technical Advisory Group on Immunisation (NTAGI) had recently also approved the qHPV after reviewing the clinical trial data of the...
NTAGI to discuss data of Gennova Pharma mRNA vaccine against COVID Ruchika Sharma12 July 2022 1:00 PM ISTThe indigenous innovative mRNA vaccine is based on the second wave driven by the Delta variant and can be kept under 2 to 8 degrees Celsius this means...
DCGI recommends allowing Serum Institute to manufacture, stockpile QHPV vaccine Rahul Verma8 July 2022 5:30 PM ISTThe Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV vaccine...
Plea questions sanctity of prescriptions generated by doctors employed by e-pharmacies, HC asks govt to reply Barsha Misra7 July 2022 2:41 PM ISTAhmedabad: Responding to a plea that questioned the sanctity of prescriptions generated on phone by medical professionals employed by e pharmacies,...
DCGI recommends allowing SII to manufacture, stockpile life-saving qHPV vaccine against cervical cancer Ruchika Sharma7 July 2022 1:30 PM ISTCervical cancer is the second-most frequent type of the disease in India among women aged between 15 and 44 years.
Include Cy-Tb injection in national TB elimination programme: SII urges MoHFW Ruchika Sharma5 July 2022 1:21 PM ISTNew Delhi: Serum Institute has requested the Union health ministry for inclusion of their Cy-Tb injection for detection of Latent-TB in the National...
COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 10:00 AM ISTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
CDSCO panel recommends emergency use nod for Gennova Biopharma mRNA COVID vaccine Ruchika Sharma28 Jun 2022 3:28 PM ISTThe vaccine - GEMCOVAC-19 - is the country's first homegrown mRNA COVID- 19 vaccine and is seen as a game-changer for the healthcare industry.
